Sensitivity of commercial Anti-SARS-CoV-2 serological assays in a high-prevalence setting
View ORCID ProfileLisa Müller, View ORCID ProfilePhilipp N. Ostermann, View ORCID ProfileAndreas Walker, Tobias Wienemann, Alexander Mertens, Ortwin Adams, Marcel Andree, Sandra Hauka, View ORCID ProfileVerena Keitel, View ORCID ProfileIngo Drexler, Veronica Di Cristanziano, Derik Franz Hermsen, Rolf Kaiser, View ORCID ProfileFriedrich Boege, Florian Klein, View ORCID ProfileHeiner Schaal, View ORCID ProfileJörg Timm, View ORCID ProfileTina Senff
doi: https://doi.org/10.1101/2020.06.11.20128686
Lisa Müller
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Philipp N. Ostermann
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Andreas Walker
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Tobias Wienemann
2Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Alexander Mertens
3Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Ortwin Adams
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Marcel Andree
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Sandra Hauka
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Verena Keitel
3Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Ingo Drexler
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Veronica Di Cristanziano
4Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
Derik Franz Hermsen
5Institute of Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Düsseldorf, Düsseldorf, Germany
Rolf Kaiser
4Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
Friedrich Boege
5Institute of Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Düsseldorf, Düsseldorf, Germany
Florian Klein
4Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
Heiner Schaal
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Jörg Timm
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Tina Senff
1Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
Posted June 12, 2020.
Sensitivity of commercial Anti-SARS-CoV-2 serological assays in a high-prevalence setting
Lisa Müller, Philipp N. Ostermann, Andreas Walker, Tobias Wienemann, Alexander Mertens, Ortwin Adams, Marcel Andree, Sandra Hauka, Verena Keitel, Ingo Drexler, Veronica Di Cristanziano, Derik Franz Hermsen, Rolf Kaiser, Friedrich Boege, Florian Klein, Heiner Schaal, Jörg Timm, Tina Senff
medRxiv 2020.06.11.20128686; doi: https://doi.org/10.1101/2020.06.11.20128686
Sensitivity of commercial Anti-SARS-CoV-2 serological assays in a high-prevalence setting
Lisa Müller, Philipp N. Ostermann, Andreas Walker, Tobias Wienemann, Alexander Mertens, Ortwin Adams, Marcel Andree, Sandra Hauka, Verena Keitel, Ingo Drexler, Veronica Di Cristanziano, Derik Franz Hermsen, Rolf Kaiser, Friedrich Boege, Florian Klein, Heiner Schaal, Jörg Timm, Tina Senff
medRxiv 2020.06.11.20128686; doi: https://doi.org/10.1101/2020.06.11.20128686
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2674)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12292)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (682)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3925)
- Nursing (212)
- Nutrition (584)
- Oncology (2064)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)